Dissemination of vancomycin-resistant enterococci among haemodialysis patients in Athens, Greece

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 6, 2004, Pages 1031-1034

  Kalocheretis, Petros ^a   Baimakou, Eleftheria ^b   Zerbala, Sinodi ^a   Papaparaskevas, Joseph ^c   Makriniotou, Ioanna ^a   Tassios, Panayotis T ^c   Iatrou, Christos ^a   Kouskouni, Evangelia ^b   Zerva, Loukia ^c  

^a GENERAL HOSPITAL OF NIKEA   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Colonization; Epidemiology; Surveillance cultures

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; STREPTOMYCIN; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLONE; CONTROLLED STUDY; DEMOGRAPHY; DRUG USE; ENTEROCOCCUS FAECIUM; ENVIRONMENT; EPIDEMIOLOGICAL DATA; FECES ANALYSIS; FEMALE; FREQUENCY ANALYSIS; GENE CLUSTER; GEOGRAPHIC DISTRIBUTION; GREECE; HEALTH CARE FACILITY; HEMODIALYSIS; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MOLECULAR PHYLOGENY; MOLECULAR TYPING; MULTIDRUG RESISTANCE; NONHUMAN; OUTPATIENT; PATIENT INFORMATION; PATIENT REFERRAL; RECTUM; RISK FACTOR; SEX DIFFERENCE; STATISTICAL ANALYSIS; VANCOMYCIN RESISTANT ENTEROCOCCUS;

AGED; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CARBON-OXYGEN LIGASES; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; GREECE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POPULATION SURVEILLANCE; PREVALENCE; RENAL DIALYSIS; VANCOMYCIN RESISTANCE;

EID: 12344254922     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh450     Document Type: Article

References (18)

1. Murray, B. E. (2000). Vancomycin-resistant enterococcal infections. New England Journal of Medicine 342, 710-21.
2. Hayden, M. K. (2000). Insights into the epidemiology and control of infection with vancomycin-resistant enterococci. Clinical Infectious Diseases 31, 1058-65.
3. Papaparaskevas, J., Stefanou, J., Vatopoulos, A. et al. (1999). The first clinical isolate of Enterococcus faecium with the VanB phenotype in a teaching hospital in Greece. Clinical Microbiology and Infection 5, 763-5.
4. Maniatis, A. N., Pournaras, S., Kanellopoulou, M. et al. (2001). Dissemination of clonally unrelated erythromycin- and glycopeptide-resistant Enterococcus faecium isolates in a tertiary Greek hospital. Journal of Clinical Microbiology 39, 4571-4.
5. Pournaras, S., Malamou-Lada, H., Maniati, M. et al. (2004). Persistence of a clone of glycopeptide-resistant Enterococcus faecalis among patients in an intensive care unit of a Greek hospital. Journal of Antimicrobial Chemotherapy 53, 109-12.
6. Sofianou, D., Pournaras, S., Giosi, M. et al. (2004). Substantially increased faecal carriage of vancomycin-resistant enterococci in a tertiary Greek hospital after a 4 year time interval. Journal of Antimicrobial Chemotherapy 54, 251-4.
7. Tokars, J. I., Frank, M., Alter, M. J. et al. (2002). National surveillance of dialysis-associated diseases in the United States. Seminars in Dialysis 15, 162-71.
8. Roghmann, M. C., Fink, J. C., Polish, L. et al. (1998). Colonization with vancomycin-resistant enterococci in chronic haemodialysis patients. American Journal of Kidney Diseases 32 254-7.
9. Atta, M. G., Eustace, J. A., Song, X. et al. (2001). Outpatient vancomycin use and vancomycin-resistant enterococcal colonization in maintenance dialysis patients. Kidney International 59, 718-24.
10. Tokars, J. I., Gehr, T., Jarvis, W. R. et al. (2001). Vancomycin-resistant enterococcal colonization in patients at seven haemodialysis centers. Kidney International 60, 1511-6.
11. Fishbane, S., Cunha, B. A., Mittal, S. K. et al. (1999). Vancomycin-resistant enterococci in haemodialysis patients is related to intravenous vancomycin use. Infection Control and Hospital Epidemiology 20, 460-2.
12. Descheemaeker, P., Ieven, M., Chapelle, S. et al. (2000). Prevalence and molecular epidemiology of glycopeptide-resistant enterococci in Belgian renal dialysis units. Journal of Infectious Diseases 181, 235-41.
13. D'Agata, E. M. C., Green, W. K., Schulman, G. et al. (2001). Vancomycin-resistant enterococci among chronic haemodialysis patients: a prospective study of acquisition. Clinical Infectious Diseases 32, 23-9.
14. Swenson, J. M., Clark, N. C., Ferraro, M. J. et al. (1994). Development of a standardized screening method for detection of vancomycin-resistant enterococci. Journal of Clinical Microbiology 32, 1700-4.
15. National Committee for Clinical Laboratory Standards. (2004). Performance Standards for Antimicrobial Susceptibility Testing: Fourteenth Informational Supplement M100-S14. NCCLS, Wayne, PA, USA.
16. Dutka-Mallen, S., Evers, S. & Courvalin, P. (1995). Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. Journal of Clinical Microbiology 33, 24-7.
17. Papaparaskevas, J., Vatopoulos, A., Tassios, P. T. et al. (2000). Diversity among high-level aminoglycoside-resistant enterococci. Journal of Antimicrobial Chemotherapy 45, 277-83.
18. Tenover, F., Arbeit, R., Goering, R. et al. (1995). Interpreting chromosomal DNA restriction patterns produced by PFGE: criteria for bacterial strain typing. Journal of Clinical Microbiology 33, 2233-9.